solution vs IR in the EU [Design Issues]

posted by talr – Israel, 2008-10-15 22:30 (6458 d 15:16 ago) – Posting: # 2538
Views: 5,229

Dear Helmut.
Thanks again.
your answers are clarifying the fact that in the absence of "common" base for comparison between reference to developed product: clinical data will be required in order to assure the similarity.

As for

❝ Unfortunatelly I have no experience with Israel's guidelines and can only

❝ refer to European practices.


Israel's guidlines if complete adoption of EU directive,
nevertheless minor changes sometimes are adopted in a specific case

:-)
I presented today the forum and our subject of "solution vs IR in the EU" to my managment and everyone were highly impressed by the professional support in this forum.
Very well done! helmut and everyone here.
Best regards,
Tali

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,572 registered users;
135 visitors (0 registered, 135 guests [including 21 identified bots]).
Forum time: 13:46 CEST (Europe/Vienna)

Scientists cannot simply hang their subjectivities
up on a hook outside the laboratory door.    Ruth Bleier

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5